Skip to main content
Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.201
-0.009 (-4.29%)
At close: Apr 28, 2026, 4:00 PM EDT
0.201
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:07 PM EDT

Sangamo Therapeutics Revenue

In the year 2025, Sangamo Therapeutics had annual revenue of $39.55M, down -31.57%. Sangamo Therapeutics had revenue of $14.23M in the quarter ending December 31, 2025, with 88.43% growth.

Revenue (ttm)
$39.55M
Revenue Growth
-31.57%
P/S Ratio
2.04
Revenue / Employee
$278,535
Employees
142
Market Cap
83.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202539.55M-18.25M-31.57%
Dec 31, 202457.80M-118.43M-67.20%
Dec 31, 2023176.23M64.93M58.34%
Dec 31, 2022111.30M598.00K0.54%
Dec 31, 2021110.70M-7.49M-6.34%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 57.95M
Pelthos Therapeutics 16.80M
Alterity Therapeutics 4.43M
Seres Therapeutics 789.00K
aTyr Pharma 190.00K
Revenue Rankings

SGMO News

More News